News & Media

 

About Abiomed and Impella® Heart Pumps

Based in Danvers, Massachusetts, USA, Abiomed, Inc. (NASDAQ: ABMD) is a leading provider of medical devices that provide circulatory and respiratory support. Our cardiac products are designed to enable the heart to rest and recover by improving blood flow and/or performing the pumping of the heart. Our easy-to-use respiratory product is designed to oxygenate the blood, while promoting mobility.

Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.

View all press releases

Media Center for Journalists

Abiomed’s media kit provides a comprehensive source of information for you to tell your story, from product images to b-roll video.

Male impella patient on green background

Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.

Contact Us

Tom Langford
Director of Communication
 
ABIOMED, Inc.
22 Cherry Hill Drive | Danvers, MA 01923
E-Mail: tlangford(at)abiomed.com
Phone: 978-882-8408

 

NPS-2567